Ocular Therapeutix Inc.

NASDAQ: OCUL · Real-Time Price · USD
12.60
-0.05 (-0.40%)
At close: Aug 15, 2025, 3:59 PM
12.80
1.59%
After-hours: Aug 15, 2025, 07:10 PM EDT

Ocular Therapeutix Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
392.1M 195.81M 102.3M 164.16M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 1.76M 1.76M
Other Long-Term Assets
1.61M 1.61M n/a n/a
Receivables
32.39M 26.18M 21.32M 21.14M
Inventory
3.04M 2.31M 1.97M 1.25M
Other Current Assets
13.46M 7.94M 4.03M 4.75M
Total Current Assets
440.99M 232.24M 129.63M 191.3M
Property-Plant & Equipment
15.33M 18.21M 17.9M 11.82M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
16.95M 19.82M 19.66M 13.59M
Total Assets
457.94M 252.06M 149.29M 204.89M
Account Payables
4.18M 4.39M 5.12M 4.59M
Deferred Revenue
128K 255K 576K 13M
Short-Term Debt
n/a n/a 1.6M 1.62M
Other Current Liabilities
35.12M 20.51M 14.99M 11.9M
Total Current Liabilities
41.35M 34.9M 31.39M 26.34M
Long-Term Debt
68.5M 74.92M 54.01M 51.44M
Other Long-Term Liabilities
32.73M 30.09M 6.44M 20.19M
Total Long-Term Liabilities
101.24M 126.03M 82.52M 90.55M
Total Liabilities
142.59M 160.93M 113.91M 116.89M
Total Debt
75.78M 83.39M 64.28M 58.98M
Common Stock
16K 12K 8K 8K
Retained Earnings
-891.08M -697.58M -616.84M -545.8M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
315.34M 91.13M 35.38M 88M
Total Investments
n/a 1.61M 1.76M 1.76M